Expression of the spliceosomal elements more consistently altered in all the HCC cohorts (EIF4A3, RBM3, ESRP2 or SRPK1) was associated with relevant clinical or molecular features of the patients. This evidence concerns the gene EIF4A3 and hepatocellular carcinoma.